PET/MR Imaging in Heart Disease.
Hybrid PET/MR imaging is a complex imaging modality that has raised high expectations not only for oncological and neurologic imaging applications, but also for cardiac imaging applications. Initially, physicians and physicists had to become accustomed to technical challenges including attenuation correction, gating, and more complex workflow and more elaborate image analysis as compared with PET/CT or standalone MR imaging. PET/MR imaging seems to be particularly valuable to assess inflammatory myocardial diseases (such as sarcoidosis), to cross-validate PET versus MR imaging data (eg, myocardial perfusion imaging), and to help validate novel biomarkers of various disease states (eg, postinfarction inflammation).
Department of Nuclear Medicine, Technical University Munich, Ismaninger Straße 22, 81675 München, Germany. Electronic address: C.Rischpler@tum.de.
Christoph
C
Rischpler
Department of Nuclear Medicine, Technical University Munich, Ismaninger Straße 22, 81675 München, Germany.
Stephan G
SG
Nekolla
D006331:Heart Diseases / Q000000981:diagnostic imaging*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D064847:Multimodal Imaging / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*; D015203:Reproducibility of Results
Cardiac imaging; Heart disease; PET/MR imaging